Immunotherapy has emerged as a revolutionary approach in the treatment of various malignancies. It leverages the body’s immune system to combat cancer, thereby reducing the adverse effects associated with traditional cancer treatments. This article aims to provide physicians with a comprehensive understanding of the fundamentals of immunotherapy.
Immunotherapy works by enhancing or suppressing the immune system's response. It can be classified into active, passive, and hybrid based on the approach. Active immunotherapy stimulates the immune system to work harder or smarter to attack cancer cells. In contrast, passive immunotherapies essentially provide the immune system with components, such as man-made immune system proteins, to improve the body's response.
Immunotherapy encompasses a wide array of therapeutic strategies. These include monoclonal antibodies that target specific parts of cancer cells, cancer vaccines, and non-specific immunotherapies. Additionally, checkpoint inhibitors that help the immune system recognize and attack cancer cells, and Chimeric Antigen Receptor (CAR) T-cell therapy, which involves altering T cells in the laboratory to attack cancer cells, are significant advances in this field.
Immunotherapy has been approved for the treatment of a variety of cancers, including lung, melanoma, head and neck, bladder, and kidney cancers. The effectiveness of immunotherapy can vary, with some patients experiencing complete remission while others may not respond. Factors influencing responsiveness include the type of cancer, its stage, and the patient's overall health.
Immunotherapy is a promising frontier in cancer treatment. Understanding its principles, types, and applications can equip physicians with the knowledge to make informed decisions about its use in patient care. As research progresses, the potential of immunotherapy continues to grow, underscoring the importance of staying abreast of developments in this rapidly evolving field.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation